The opioid marketing machine
Unlock the Editor’s Digest for free
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.
Purdue Pharma faces more than 1,000 lawsuits claiming it ignited and fuelled the US opioid crisis, reports David Crow. Prosecutors say the company exaggerated the benefits of its painkiller OxyContin, but through their ownership of Rhodes Pharma, Purdue’s owners also have a far bigger market share than was realised.
Comments